| Name | 4-Piperidin-4-ylmorpholine |
|---|---|
| Synonyms |
MFCD03274733
Morpholine, 4-(4-piperidinyl)-, hydrochloride (1:2) 4-(Piperidin-4-YL)-Morpholine 4-piperidin-4-ylmorpholine 4-(Piperidin-4-yl)morpholine 4-(4-Piperidinyl) morpholine 4-(Piperidin-4-Yl)Morpholine Dihydrochloride 4-(4-Piperidinyl)morpholine dihydrochloride 4-Morpholinopiperidine |
| Density | 1.033 g/cm3 |
|---|---|
| Boiling Point | 256.3ºC at 760 mmHg |
| Melting Point | 40-43ºC |
| Molecular Formula | C9H20Cl2N2O |
| Molecular Weight | 243.174 |
| Flash Point | 108.8ºC |
| Exact Mass | 242.095276 |
| PSA | 24.50000 |
| LogP | 1.94130 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | Eyeshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | Xi:Irritant; |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3.0 |
| HS Code | 2934999090 |
|
~91%
53617-35-9 |
| Literature: Huchler, Guenther; Rall, Werner; Ries, Uwe Patent: US2008/45705 A1, 2008 ; Location in patent: Page/Page column 10-11 ; |
|
~%
53617-35-9 |
| Literature: US2005/239843 A1, ; Page/Page column 15 ; |
|
~%
53617-35-9 |
| Literature: US2003/203909 A1, ; |
|
~%
53617-35-9 |
| Literature: WO2009/131246 A1, ; Page/Page column 88 ; |
|
~%
53617-35-9 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 22, # 9 p. 3157 - 3162 |
|
~%
53617-35-9 |
| Literature: Journal of Organic Chemistry, , vol. 26, p. 3805 - 3808 |
|
~%
53617-35-9 |
| Literature: US6288061 B1, ; |
|
~%
53617-35-9 |
| Literature: US2011/87021 A1, ; |
|
~%
53617-35-9 |
| Literature: Bioorganic and Medicinal Chemistry Letters, , vol. 22, # 9 p. 3157 - 3162 |
| HS Code | 2934999090 |
|---|---|
| Summary | 2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |